Amicus Therapeutics (FOLD) EV/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | -15.2 | -18.5 | -47.2 | 104.2 | 85.1 | 66.4 | |
| Changes by years, y/y, % | -38% | +21% | +155% | -321% | -18% | |||
Amicus Therapeutics. EV/EBITDA
Amicus Therapeutics. EV/EBITDA, changes, %
Amicus Therapeutics (FOLD) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | 102.4 | 50.4 | 59.8 | 44.0 | 85.3 | 66.4 | |
| Changes by years, y/y, % | -318% | -208% | -175% | -112% | -17% | |||
| Changes by quarters, q/q, % | -127% | -51% | +19% | -26% | +94% | |||